Search Within

Jacqueline Bromberg

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Breast Medicine Service (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Hematologic Malignancies, Division of (7)
  5. Solid Tumor Oncology Division (7)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (5)

More Groups

People
  1. Ross Levine (3)
  2. Sizhi Gao (3)
  3. Bayard Clarkson (2)
  4. Darren Veach (2)
  5. Elisa De Stanchina (2)
  6. Kenneth Leslie (2)

More People

Years
  1. 2018 (2)
  2. 2016 (1)
  3. 2015 (1)
  4. 2010 (1)
  5. 2008 (1)
  6. 2007 (1)
Publications
  1. Blood (1)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. Journal of Clinical Investigation (1)
  5. Journal of Vascular and Interventional Radiology (1)
  6. Radiology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Association for the Advancement of Science (1)
  3. American Society for Clinical Investigation (1)
  4. American Society of Hematology (1)
  5. Elsevier Science, Inc. (1)
  6. Radiological Society of North America, Inc. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of PI3K pathway mutations with early positron-emission tomography/CT imaging response after radioembolization for breast cancer liver metastases: Results of a single-center retrospective pilot study
    Journal Article

    Deipolyi, A. R.; Riedl, C. C.; Bromberg, J.; Chandarlapaty, S.; Klebanoff, C. A.; Sofocleous, C. T.; Yarmohammadi, H.; Brody, L. A.; Boas, F. E.; Ziv, E.
    Journal of Vascular and Interventional Radiology (2018)

    Fulltext@MSK | Save
  • In vivo PET assay of tumor glutamine flux and metabolism: In-human trial of (18)F-(2S,4R)-4-fluoroglutamine
    Journal Article

    Dunphy, M. P. S.; Harding, J. J.; Venneti, S.; Zhang, H.; Burnazi, E. M.; Bromberg, J.; Omuro, A. M.; Hsieh, J. J.; Mellinghoff, I. K.; Staton, K.; more...
    Radiology (2018)

    Fulltext@MSK | Save
  • JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors
    Journal Article

    Gao, S. P.; Chang, Q.; Mao, N.; Daly, L. A.; Vogel, R.; Chan, T.; Liu, S. H.; Bournazou, E.; Schori, E.; Zhang, H.; more...
    Science Signaling (2016)

    Fulltext@MSK | Save
  • JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
    Journal Article

    Kleppe, M.; Kwak, M.; Koppikar, P.; Riester, M.; Keller, M.; Bastian, L.; Hricik, T.; Bhagwat, N.; McKenney, A. S.; Papalexi, E.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
    Journal Article

    Koppikar, P.; Abdel-Wahab, O.; Hedvat, C.; Marubayashi, S.; Patel, J.; Goel, A.; Kucine, N.; Gardner, J. R.; Combs, A. P.; Vaddi, K.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate Stat3 activation via IL-6 production in human lung adenocarcinomas
    Meeting Abstract

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
    Journal Article

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Journal of Clinical Investigation (2007)

    Fulltext@MSK | Save